ADPT vs RDNT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ADPT · Adaptive Biotechnologies$27.93 ▼ 0.43%
RDNT · RadNet$69.71 ▲ 0.29%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ADPT +36.5%
- RDNT -17.5%
Head to head
| Metric | ADPT | RDNT |
|---|---|---|
| Price | $27.93 | $69.71 |
| Change today | ▼ 0.43% | ▲ 0.29% |
| Market cap | $4.52B | $5.49B |
| Return, 3 months | +9.3% | -6.7% |
| Return, year to date | +72.0% | -2.3% |
| Return, 1 year | +50.1% | -16.0% |
| P/E (TTM) | – | – |
| P/B | 25.6 | 4.9 |
| P/E percentile vs own 5y | 4th | 27th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -10.7% | +22.1% |
| Net profit growth (YoY) | -70.6% | +37.9% |
| Gross margin | 74.2% | 11.5% |
| Operating margin | -16.2% | 4.1% |
| Net margin | -23.7% | -0.9% |
| Return on equity | -37.1% | -2.1% |
| Analyst target vs. price | +19.7% | +35.6% |
| Analyst buy share | 88% | 100% |
| RSI (14) | 52 | 39 |
| 30-day volatility | 55.7% | 42.6% |
| Max drawdown, 1 year | -39.3% | -38.6% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- RDNT is the largest of the group by market value.
- ADPT has returned the most over the past year.
- RDNT is growing revenue fastest.
- RDNT keeps the most profit per dollar of sales.
- RDNT has been the calmest stock over the last 30 days.